(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
The inspiration for this text was the 1988 volume by Alder and Zbinden, written before the ICH harmonization process for drug safety evaluation (or its ISO analog for device biocompatibility evaluation) had been initiated or come to force. Since then, much has changed in both the world and practice of medicine and the regulation of drugs. The intent of this volume is to provide similar guidance as to what nonclinical safety assessment tests need to be performed to move a drug into man, through development and to market approved (this intent was subsequently extended to cover the closely related medical device biotechnology, and combination product fields) in a concise, abbreviated manner for all the major world market countries.
Contents:
Preface
1. Introduction to Safety Assessment in Drug and Medical Device Development
2. Drugs: The General Case
3. Ind Enabling Toxicology Programs
4. Nonclinical Safety Evaluation Studies Conducted To Support Continued Clinical Development
5. Supporting Marketing Applications
6. Special Therapeutic Category And Route Of Administration Cases
7. Device Safety Evaluation
Appendix A
INDEX
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: October, 2010
Pages: 140
Weight: 377g
Availability: Available
Subcategories: Pharmacology
Publisher recommends